• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Caristo Diagnostics Receives FDA De Novo Authorization for CaRi-Heart AI Platform

by Jasmine Pennic 07/29/2026 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Caristo Diagnostics Receives FDA De Novo Authorization for CaRi-Heart AI Platform

What You Should Know

  • Oxford spin-out Caristo Diagnostics has secured FDA De Novo authorization for CaRi-Heart®, making it the first and only technology authorized in the U.S. to quantify coronary inflammation from routine Coronary CT Angiography (CCTA).
  • CaRi-Heart uses advanced AI to analyze inflammation-driven changes in the pericoronary adipose tissue, generating a Fat Attenuation Index Score (FAI-Score™) and a 10-year personalized cardiovascular mortality risk estimate.
  • The FDA clearance addresses the critical diagnostic gap where ~50% of first-time heart attacks occur in patients previously classified as “low risk” by traditional calcium scoring or standard CCTA.
  • Supported by peer-reviewed evidence in The Lancet and clinical validation through the Oxford Risk Factors And Non-invasive imaging study (ORFAN), which tracks up to 250,000 patients globally.

Pericoronary Fat Attenuation and CPT Billing Architecture

Spun out of the University of Oxford, Caristo’s AI platform quantifies pericoronary fat attenuation directly from routine CCTA scans, offering U.S. clinicians a non-invasive method to measure active coronary inflammation. CaRi-Heart integrates advanced spatial computer vision and bio-imaging algorithms directly into existing radiology and cardiology imaging workflows:

  • Fat Attenuation Index (FAI-Score™): Analyzes subtle composition changes in the fat surrounding the coronary arteries (pericoronary adipose tissue) triggered by inflammatory signals released from the arterial wall.
  • 10-Year Mortality Prediction: Combines the FAI-Score™ with anatomical plaque metrics and patient demographics to produce the CaRi-Heart® Risk Score—a personalized 10-year estimate of cardiovascular mortality.
  • Synergy with CaRi-Plaque®: Complements Caristo’s FDA-cleared CaRi-Plaque® software to deliver a comprehensive dual-assessment of both structural plaque burden and active biological inflammation.
  • Commercial CPT Billing Infrastructure: Supported by AMA Category III CPT codes 0992T and 0993T (effective January 1, 2026), providing health systems and outpatient imaging centers with established reimbursement pathways.

“We’ve spent decades building the scientific case that coronary inflammation is an important contributor to the development and progression of coronary plaque,” stated Ron Blankstein, M.D., of Harvard Medical School and Brigham and Women’s Hospital. “And now for the first time, clinicians can specifically measure coronary inflammation, obtaining a more complete picture of cardiovascular risk compared to standard CCTA, or calcium scoring alone.”

By converting routine, existing CCTA scans into high-value inflammatory risk assessments without requiring extra radiation or contrast injections, Caristo unlocks immediate clinical value for health systems.

Furthermore, having pre-established Category III CPT codes ahead of its U.S. commercial push removes the primary adoption hurdle facing advanced AI diagnostic tools.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: FDA Clearance

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |